Elite controllers or suppressors (ES) are HIV-1-infected patients who maintain viral loads of <50 copies/ml without antiretroviral therapy. While HLA-B*57 and B*5801 alleles are overrepresented in ES, many HLA-B*57/B*5801 patients become chronic progressors (CP). We show here that HIV-1 infection results in similar levels of downregulation of HLA-B*57 and HLA-B*5801 molecules on primary CD4+ T cells from ES and CP. Thus, differences in HIV-1-mediated downregulation of HLA-B*57/B*5801 molecules do not distinguish ES from CP.
Get full access to this article
View all access options for this article.
References
1.
BlanksonJN. Effector mechanisms in HIV-1 infected elite controllers: Highly active immune responses?Antiviral Res, 2010; 85,1:295–302.
2.
BlanksonJN, BaileyJR, ThayilSet al.Isolation and characterization of replication-competent human immunodeficiency virus type 1 from a subset of elite suppressors. J Virol, 2007; 81,5:2508–2518.
3.
BaileyJR, O'ConnellK, YangHCet al.Transmission of human immunodeficiency virus type 1 from a patient who developed AIDS to an elite suppressor. J Virol, 2008; 82,15:7395–7410.
4.
MiguelesSA, SabbaghianMS, ShupertWLet al.HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors. Proc Natl Acad Sci USA, 2000; 97,6:2709–2714.
5.
MiguelesSA, OsborneCM, RoyceCet al.Lytic granule loading of CD8 + T cells is required for HIV-infected cell elimination associated with immune control. Immunity, 2008; 29,6:1009–1021.
Saez-CirionA, LacabaratzC, LambotteOet al.HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype. Proc Natl Acad Sci USA, 2007; 104,16:6776–6781.
8.
MiguelesSA, LaboricoAC, ShupertWLet al.HIV-specific CD8 + T cell proliferation is coupled to perforin expression and is maintained in nonprogressors. Nature Immunol, 2002; 3,11:1061–1068.
9.
SchwartzO, MarechalV, Le GallS, LemonnierF, HeardJM. Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 nef protein. Nature Med, 1996; 2,3:338–342.
10.
CohenGB, GandhiRT, DavisDMet al.The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. Immunity, 1999; 10,6:661–71.
11.
NouE, ZhouY, NouDD, BlanksonJN. Effective downregulation of HLA-A*2 and HLA-B*57 by primary human immunodeficiency virus type 1 isolates cultured from elite suppressors. J Virol, 2009; 83,13:6941–6946.
12.
FriedrichTC, PiaskowskiSM, LeonEJet al.High viremia is associated with high levels of in vivo major histocompatibility complex class I downregulation in rhesus macaques infected with simian immunodeficiency virus SIVmac239. J Virol, 2010; 84,10:5443–5447.
13.
ZhangH, ZhouY, AlcockCet al.Novel single-cell-level phenotypic assay for residual drug susceptibility and reduced replication capacity of drug-resistant human immunodeficiency virus type 1. J Virol, 2004; 78,4:1718–1729.
14.
MartinAM, KruegerR, AlmeidaCA, NolanD, PhillipsE, MallalS. A sensitive and rapid alternative to HLA typing as a genetic screening test for abacavir hypersensitivity syndrome. Pharmacogenet Genomics, 2006; 16,5:353–357.
15.
HanY, LaiJ, Barditch-CrovoPet al.The role of protective HCP5 and HLA-C associated polymorphisms in the control of HIV-1 replication in a subset of elite suppressors. AIDS (London, England), 2008; 22,4:541–544.
16.
GarciaJV, MillerAD. Serine phosphorylation-independent downregulation of cell-surface CD4 by nef. Nature, 1991; 350,6318:508–5011.
